EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breynia cernua: Chemical Profiling of Volatile Compounds in the Stem Extract and Its Antioxidant, Antibacterial, Antiplasmodial and Anticancer Activity In Vitro and In Silico

Hesti Lina Wiraswati iD, Nisa Fauziah iD, Gita Widya Pradini, Dikdik Kurnia iD, Reza Abdul Kodir iD, Afiat Berbudi, Annisa Retno Arimdayu iD, Amila Laelalugina, Supandi, Ilma Fauziah Ma'ruf iD

Metabolites · 15.02.2023 · 13 (2) · 281

DOI: 10.3390/metabo13020281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 15.02.2023. Verfasst von Hesti Lina Wiraswati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Padjadjaran University, Directorate of Research and Community Engagement Universitas Padjadjaran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breynia cernua has been used as an alternative medicine for wounds, smallpox, cervical cancer, and breast cancer. This plant is a potential source of new plant-derived drugs to cure numerous diseases for its multiple therapeutic functions. An in vitro study revealed that the methanol extract of B. cernua (stem) exhibits antioxidant activity according to DPPH and SOD methods, with IC50 values of 33 and 8.13 ppm, respectively. The extract also exerts antibacterial activity against Staphylococcus aureus with minimum bactericidal concentration of 1875 ppm. Further analysis revealed that the extract with a concentration of 1–2 ppm protects erythrocytes from the ring formation stage of Plasmodium falciparum, while the extract with a concentration of 1600 ppm induced apoptosis in the MCF-7 breast cancer cell line. GC–MS analysis showed 45 bioactive compounds consisting of cyclic, alkyl halide, organosulfur, and organoarsenic compounds. Virtual screening via a blind docking approach was conducted to analyze the binding affinity of each metabolite against various target proteins. The results unveiled that two compounds, namely, N-[β-hydroxy-β-[4-[1-adamantyl-6,8-dichloro]quinolyl]ethyl]piperidine and 1,3-phenylene, bis(3-phenylpropenoate), demonstrated the best binding score toward four tested proteins with a binding affinity varying from −8.3 to −10.8 kcal/mol. Site-specific docking analysis showed that the two compounds showed similar binding energy with native ligands. This finding indicated that the two phenolic compounds could be novel antioxidant, antibacterial, antiplasmodial, and anticancer drugs. A thorough analysis by monitoring drug likeness and pharmacokinetics revealed that almost all the identified compounds can be considered as drugs, and they have good solubility, oral bioavailability, and synthetic accessibility. Altogether, the in vitro and in silico analysis suggested that the extract of B. cernua (stem) contains various compounds that might be correlated with its bioactivities.

Schlagwörter

Stichwörter der Autor:innen

B. cernua (stem) methanol extractantibacterialanticancerantioxidantantiplasmodialdrug likenessmetabolite profilingmolecular dockingpharmacokinetics

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia.
  • Advance Biomedical Laboratory, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia.
  • Infection Working Group, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia.
  • Oncology and Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia.
  • Departement of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia.
  • Pharmacy Study Program, Faculty of Mathematics and Natural Sciences, Universitas Islam Bandung, Bandung 40116, Indonesia.

ORCID-Profile: Hesti Lina Wiraswati, Nisa Fauziah, Dikdik Kurnia, Reza Abdul Kodir, Annisa Retno Arimdayu, Ilma Fauziah Ma'ruf

Förderung

  • Padjadjaran University
  • Directorate of Research and Community Engagement Universitas Padjadjaran

Zitieren

APA

Wiraswati, H. L., Fauziah, N., Pradini, G. W., Kurnia, D., Kodir, R. A., Berbudi, A., Arimdayu, A. R., Laelalugina, A., Supandi, & Ma'ruf, I. F. (2023). Breynia cernua: Chemical Profiling of Volatile Compounds in the Stem Extract and Its Antioxidant, Antibacterial, Antiplasmodial and Anticancer Activity In Vitro and In Silico. Metabolites, 13(2), 281. https://doi.org/10.3390/metabo13020281

Vancouver

Wiraswati HL, Fauziah N, Pradini GW, Kurnia D, Kodir RA, Berbudi A, et al. Breynia cernua: Chemical Profiling of Volatile Compounds in the Stem Extract and Its Antioxidant, Antibacterial, Antiplasmodial and Anticancer Activity In Vitro and In Silico. Metabolites. 2023;13(2):281. doi:10.3390/metabo13020281

BibTeX
@article{Wiraswati2023,
  author = {Wiraswati, Hesti Lina and Fauziah, Nisa and Pradini, Gita Widya and Kurnia, Dikdik and Kodir, Reza Abdul and Berbudi, Afiat and Arimdayu, Annisa Retno and Laelalugina, Amila and Supandi and Ma'ruf, Ilma Fauziah},
  title = {Breynia cernua: Chemical Profiling of Volatile Compounds in the Stem Extract and Its Antioxidant, Antibacterial, Antiplasmodial and Anticancer Activity In Vitro and In Silico},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {281},
  doi = {10.3390/metabo13020281}
}
Kostenlos starten →